Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
:::

趙偉廷 (Wei Ting Chao)

[簡介]

  • 學歷
    • 輔仁大學醫學系
    • 國立陽明交通大學 臨床醫學研究所博士 (2026-迄今)
  • 經歷
    現職:
    • - 迄今 臺北榮民總醫院婦女醫學部 主治醫師 (2023-迄今)
    • - 迄今 國立陽明交通大學醫學系 兼任講師 (2022-迄今)
    • - 迄今 教育部 部定講師 (2023-迄今)
    • - 迄今 臺灣更年期醫學會 副秘書長 (2021-迄今)
    • - 迄今 台灣福爾摩莎婦女泌尿醫學會秘書長 (2022-迄今)
    經歷:
    • - 日本龜田國際醫療中心進修 (野村昌良教授指導)
    • - 美國達拉斯 Baylor Scott & White Health 中心進修 ( Liza Johannesson 教授指導)
    • - 臺北榮總婦女醫學部最佳住院醫師論文獎
    • - 臺灣婦科醫學會口頭論文獲獎
    • - 臺北榮民總醫院 婦女醫學部 最佳教學住院醫師
    • - 臺北榮民總醫院 婦女醫學部 婦科暨婦女泌尿研修醫師
  • 醫療專長
    1. 尿失禁及脫垂手術、間質性膀胱炎、陰道雷射、變性手術(女變男)(婦女泌尿專科醫師)
    2. 子宮內膜癌、子宮頸癌、卵巢癌
    3. 達文西機械手臂輔助婦科手術醫師認證
    4. 腹腔鏡微創手術(含單孔)、子宮鏡微創手術
    5. 孕前產檢 高危險妊娠 24 小時接生(自然產、剖腹產)產前超音波 (周產期專科醫師)
    6. 月經不規則、不正常陰道出血、經痛、多囊性卵巢、更年期
    7. 子宮肌瘤、子宮肌腺症、巧克力囊腫、子宮內膜異位、畸胎瘤、卵巢囊腫
  • 證照
    台灣周產期醫學會專科醫師 臺灣福爾摩莎婦女泌尿醫學會 專科醫師 臺灣婦女泌尿暨骨盆醫學會 專科醫師 教育部部定講師 臺灣婦產科專科醫師 達文西機械手臂輔助婦科手術醫師認證
  • 語言專長
    國語、台語、英語

[著作]

  1. Wei-Ting Chao, Chia-Hao Liu, Yi-Jen Chen, Hua-Hsi Wu, Chi-Mu Chuang* and Peng-Hui Wang*: Neurofibroma involving obturator nerve mimicking an adnexal mass: a rare case report and PRISMA-driven systematic review. J Ovarian Res 11, 14 (2018)(IF =4.234, R/C=6/30, Reproductive biology)
     
  2. Wei-Ting Chao, Chia-Hao Liu, Chiung-Ru Lai, Yi-Jen Chen, Chi-Mu Chuang* and Peng-Hui Wang*: Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review. J Ovarian Res 11, 52 (2018) (IF =4.234, R/C=6/30, Reproductive biology)
     
  3. Chia-Hao Liu, MD, Wei-Ting Chao, Shih-Chieh Lin, Hei-Yu Lau, Hua-Hsi Wu, Peng-Hui Wang∗ : Malignant perivascular epithelioid cell tumor in the female genital tract Preferred reporting items for systematic reviews and meta-analyses. MEDICINE (2019) 98:2(e14072)(IF = 0.5, R/C=99/167, Medicine, general and internal)
     
  4. Wei-Ting Chao, Ching-Hui Chien, Chung-Ru Lai, Hui-Ju Wu, and Chi-Mu Chuang∗ : Evaluation of a Simple and Safe Tumor Drilling Technique to Potentiate the Effect of Intraperitoneal Chemotherapy in the Treatment of Recurrent Epithelial Ovarian, Tubal, and Peritoneal Cancer: A Matched Retrospective Cohort Study. Cancer control (2019) Volume 26: 1-8(IF = 3.302, R/C =167/242, Oncology)
     
  5. Wei-Ting Chao, Ling-Yu Jiang, Guan-Yeu Chen, Peng-Hui Wang, Hua-Hsi Wu, Yi-Jen Chen* : Right postoperative pleural effusion and pulmonary embolism following laparoscopic gynecological surgery: A rare case report and PRISMA-driven systematic review. Journal of the Chinese Medical Association(2019), Volume 82 - Issue 12 - p 957-961(IF=2.743, R/C=62/167, Medicine, general and internal)
     
  6. Horng HC, Chao WT, Chen JF, Chang CP, Wang PH, Chang PL. Home-based noninvasive pelvic floor muscle training device to assist women in performing Kegel exercise in the management of stress urinary incontinence. J Chin Med Assoc. 2022 Apr 1;85(4):484-490.
     
  7. Wei-Ting Chao, Hsin-Yi Huang, Guan-Yeu Chen, Chia-Hao Liu, I-San Chan, Chia-Pei Chang, Yi-Jen Chen, Peng-Hui Wang, Huann-Cheng Horng* : Efficacy and Safety of "I-stop-mini adjustable" Sling System Versus Transobturator Midurethral "Obtryx" Sling System in Stress Urinary Incontinence: A Retrospective Cohort Study. Journal of Minimally Invasive Gynecology (2021) Dec 10:S1553-4650(21)01323-6. (IF=4.137, R/C=14/83, OBSTETRICS & GYNECOLOGY)
     
  8. Wei-Ting Chao, Hui-Hsuan Ke, Shu-Huei Shen, Chang-Ching Yeh, Peng-Hui Wang, Chiu-Ming Ho*, Huann-Cheng Horng*: A theoretical analysis of prophylactic common iliac arterial occlusion for potential massive bleeding during cesarean delivery: Decision making considerations d A 2-year retrospective study (IF=1.705, R/C=72/83, OBSTETRICS & GYNECOLOGY)
     
  9. Chao WT, Chen GY, Liu CH, Chang CP, Wang PH, Horng HC*. Efficacy of the new adjustable sling system "I-stop-mini" in women with stress urinary incontinence and intrinsic sphincter deficiency: A retrospective cohort study. Int J Gynaecol Obstet. 2022 Jul 3. doi: 10.1002/ijgo.14327. Epub ahead of print. PMID: 35780463.
     
  10. Chao WT, Liu CH, Yang ST, Chen YJ, Wang PH, Horng HC. Efficacy of minimally invasive pectopexy with concomitant I-stop-mini sling for women with pelvic organ prolapse and overt stress urinary incontinence: A retrospective cohort study. Int J Gynaecol Obstet. 2023 Aug;162(2):552-561. doi: 10.1002/ijgo.14758. Epub 2023 Mar 27. PMID: 36971496.
     
  11. Wu HH, Wang PH, Chen YJ, Chao WT. Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study. J Formos Med Assoc. 2024 Aug 20:S0929-6646(24)00382-6. doi: 10.1016/j.jfma.2024.08.014. Epub ahead of print. PMID: 39168744.
     
  12. Chao WT, Liu CH, Yang ST, Lin CH, Wang LW, Wang PH. α2,3-Sialyltransferase (ST3Gal1) regulates endometrioid-type epithelial ovarian cancer cell migration and invasion via VEGF-R2/JAK2/STAT3 signaling cascades. Int J Gynaecol Obstet. 2026 May 4. doi: 10.1002/ijgo.71057. Epub ahead of print.
     
  13. Chao WT, Sung YW, Huang KJ, Yeh LS, Sheu BC, Chang WC, Peng SH, Lin PH, Wang PH. PARP inhibitor maintenance takes advantages in advanced epithelial ovarian cancer but May show a negative impact while recurrence occurs: a multi-center retrospective study in Taiwan. J Gynecol Oncol. 2026 Feb 24. doi: 10.3802/jgo.2026.37.e75. Epub ahead of print.
     
  14. Liu CH, Chao WT, Yang ST, Lin CH, Wen KC, Wang PH. Programmed death-ligand 1 upregulation is associated with poor prognosis in patients with epithelial ovarian cancer. J Chin Med Assoc. 2026 Jan 1;89(1):25-34. doi: 10.1097/JCMA.0000000000001317. Epub 2025 Nov 11.
     
  15. Chao WT, Liu CH, Wang PH. Impact of sacrocolpopexy on sexual function and de novo stress urinary incontinence. Taiwan J Obstet Gynecol. 2025 Nov;64(6):932-934. doi: 10.1016/j.tjog.2025.09.002
     
  16. Chao WT, Liu CH, Wang PH. The role and potential effects of relaxation exercises in the treatment of primary dysmenorrhea. Taiwan J Obstet Gynecol. 2025 Sep;64(5):765-766. doi: 10.1016/j.tjog.2025.07.016.
     
  17. Liu CH, Yang ST, Chao WT, Lin CH, Lee YC, Lai CR, Hsieh SL, Wang LW, Wang PH. Targeting the ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) as a potential therapeutic strategy to overcome anti-VEGF resistance in endometrial cancer. Int J Gynaecol Obstet. 2025 Dec;171(3):1343-1354. doi: 10.1002/ijgo.70292.